Diabetes

NEW YORK — The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

GBI Research announced the release of a study Tuesday indicating that the market will grow from 2012's $20.4 billion to $38.8 billion by 2019, at an annual growth rate of 10.2%. The United States' market, meanwhile, will more than double, from $12.7 billion last year to $27.2 billion in 2019.

ABBOTT PARK, Ill. — Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system, Abbott noted. 

GREENWICH, Conn. — Homeostasis Labs was named "Best New Product" by retail buyers attending the ECRM Home Health Care conference last month for a new sugar-free line of dietary supplements formulated to boost health for people with diabetes. 

SEATTLE — Bartell Drugs will play a prominent role at a diabetes expo in Seattle this weekend, the retail pharmacy chain said Wednesday.

ALBANY, N.Y. — Customers who recycle bottles and cans with deposit values at Greenback Redemption Centers in Hannaford supermarkets in New York state will have the option of donating the money to local charities.

BIRMINGHAM, Ala. — Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said Friday.

The company announced that it had hired IZOD IndyCar Series Charlie Kimball as spokesman for its Race with Insulin contest. Kimball, the first licensed driver with diabetes to race at the highest level of the series, was diagnosed with the disease during a routine doctor visit in 2007 while racing in Europe and is a user of Novo Nordisk's NovoLog (insulin aspart [rDNA origin]).

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug made by Johnson & Johnson for treating Type 2 diabetes, the agency said.

The FDA announced the approval of J&J subsidiary Janssen Pharmaceuticals' Invokana (canagliflozin) tablets, designed for use with diet and exercise to improve blood-sugar control in adults with the disease.

ATLANTA — Coca-Cola has filed a patent application with the U.S. Patent and Trademark Office for a new sugar-free beverage with added fiber, according to a report from the Atlanta Business Chronicle.